← Back to Search

Behavioral Intervention

Text Message Reminders for COVID-19 Testing (PEACH2 Trial)

N/A

Waitlist Available

Led By Mary Beth Weber, PhD, MPH

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At-risk for diabetes, have diabetes, or are a family caregiver of someone living with diabetes

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 4 (completion of intervention), and month 12

Awards & highlights

PEACH2 Trial Summary

This trial studies how diabetes affects people over time. Participants are randomized & followed for 10 months to compare effects of an intervention for 4 months.

Who is the study for?

This trial is for English-speaking individuals in Georgia, USA who are at risk for diabetes, have diabetes, or care for someone with diabetes. They must agree to receive and respond to text messages and be willing to be randomly placed into different groups of the study.Check my eligibility

What is being tested?

The PEACH2 study is testing how effective personalized and non-personalized text message 'nudges' are at encouraging people to engage in COVID-19 testing. Participants will either receive these nudges or be in a control group without them over a period of 4 months.See study design

What are the potential side effects?

Since this trial involves text messaging interventions rather than medical treatments, there are no direct physical side effects associated with participating. However, participants may experience an increase in screen time.

PEACH2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am at risk for diabetes, have diabetes, or care for someone with diabetes.

PEACH2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 4 (completion of intervention), and month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 4 (completion of intervention), and month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 4 (completion of intervention), and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Percent of Participants Using a COVID-19 Test

Secondary outcome measures

Change in Frequency of Taking a COVID-19 Test

Change in Number of Participants Receiving Annual COVID-19 Vaccination

Change in the Number of Participants Adhering to COVID-19 Prevention Behaviors

PEACH2 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Project PEACH2 InterventionExperimental Treatment2 Interventions

In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention will be sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.

Group II: Control GroupActive Control2 Interventions

Participants randomized to the control group will receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,559,973 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,314,466 Total Patients Enrolled

Morehouse School of MedicineOTHER

20 Previous Clinical Trials

15,551 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial recruiting participants at present?

"According to clinicaltrials.gov, this research study is no longer recruiting patients. It was initially registered on the 12th of December 2023 and had its most current update on November 17th of that same year. Although recruitment has concluded for this trial, 700 other trials are currently searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Engagement and COVID-19 Testing for Health

Mary Beth Weber 2023. "Promoting Engagement and COVID-19 Testing for Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06141850.

All > Paid Studies Atlanta